Abstract Introduction: Cancer is recognized as one of the leading causes of mortality worldwide and remains a major global health challenge. Among the various types of cancer, gastric cancer is considered one of the most aggressive and prevalent malignancies due to its high incidence rate, late diagnosis, and poor prognosis. The AGS cell line is widely used as a reliable in vitro model for studying human gastric adenocarcinoma because of its adhesive growth pattern, relatively rapid proliferation, and preservation of the invasive characteristics of primary tumor cells. Conventional therapeutic approaches for gastric cancer, including surgery, radiotherapy, and chemotherapy, have shown partial clinical success; however, these methods are frequently associated with serious limitations such as systemic toxicity, damage to healthy tissues, severe side effects, and the development of drug resistance. Consequently, the development of advanced drug delivery systems has attracted considerable attention as a promising strategy to improve therapeutic efficacy while minimizing adverse effects. In this regard, nanotechnology has emerged as a powerful platform for the design of smart nanocarriers capable of enhancing drug stability, improving bioavailability, and enabling controlled and targeted drug release. Cisplatin is one of the most important chemotherapeutic agents used in the treatment of gastric cancer and exerts its anticancer activity primarily through binding to DNA, disrupting replication and transcription processes, and ultimately inducing apoptosis. Nevertheless, its clinical application is limited by severe toxicity and acquired drug resistance. Cellulose nanocrystals have gained significant attention in drug delivery systems owing to their biodegradability, high mechanical strength, structural stability, and ability to provide sustained and controlled drug release. In addition, bovine serum albumin is considered an ideal biological carrier because of its excellent biocompatibility, low toxicity, biodegradability, and natural tendency to accumulate in tumor tissues. Polyvinyl alcohol also plays an important role as a biocompatible polymeric matrix in the fabrication of stable nanocarriers. Furthermore, hyaluronic acid serves as a targeting ligand through its specific interaction with CD44 receptors, which are overexpressed on the surface of many cancer cells, including gastric cancer cells. This targeted interaction facilitates the selective uptake of nanoparticles by tumor cells and significantly enhances the efficiency of targeted drug delivery systems.
Aims: The aim of this study was to design and evaluate a smart nanocarrier system based on cellulose nanocrystals, polyvinyl alcohol, bovine serum albumin, and hyaluronic acid for the targeted delivery of cisplatin to gastric cancer cells. This study sought to improve drug stability, controlled release behavior, selective cellular uptake, and reduced toxicity toward normal cells by utilizing the biocompatible and targeting properties of these components. In addition, the cytotoxicity and anticancer selectivity of the synthesized nanoparticles were investigated in the AGS gastric cancer cell line to evaluate the potential efficiency of this nanocarrier system in enhancing the therapeutic performance of gastric cancer treatment.
Materials and methods: In this study, cellulose nanocrystals were extracted from raw cellulose through controlled sulfuric acid hydrolysis using 64% sulfuric acid, followed by ultrasonication, centrifugation, and dialysis to obtain both stable suspensions and freeze-dried powders. Cisplatin was subsequently loaded onto cellulose nanocrystals at different concentrations, and the drug-loading efficiency was determined spectrophotometrically at 370 nm. Multifunctional BSA (Bovine Serum Albumin)-PVA (Polyvinyl Alcohol)-CNC (Cellulose Nanocrystals)-CDP (Cisplatin) nanoparticles coated with PEG-hyaluronic acid were then synthesized by initially coating the drug-loaded cellulose nanocrystals with bovine serum albumin, followed by the formation of a stable hydrogel network using polyvinyl alcohol. To improve targeting ability and biological stability, the nanoparticle surface was further functionalized with NH2-PEG-HA in the presence of EDC/NHS as a coupling agent, and the final suspension was purified by dialysis before further analyses. The physicochemical properties of the synthesized nanoparticles, including crystalline structure, thermal stability, particle size, and zeta potential, were characterized using X-ray Diffraction (XRD), Thermogravimetric Analysis (TGA), and Dynamic Light Scattering (DLS) analyses, respectively. In addition, the release kinetics of cisplatin from the nanocapsules were investigated under different pH conditions simulating normal and tumor microenvironments, and the obtained data were analyzed using the Korsmeyer–Peppas kinetic model. To evaluate biocompatibility and selective cytotoxicity, AGS gastric cancer cells and normal GES-1 gastric epithelial cells were treated with the synthesized nanocapsules and free cisplatin, followed by MTT assay for IC50 determination. Furthermore, the selectivity index (SI) was calculated to assess preferential toxicity toward cancer cells. Finally, apoptosis induction was evaluated using Annexin V/PI staining and flow cytometry. All experiments were performed in triplicate, and the data were statistically analyzed using one-way ANOVA followed by Duncan’s multiple range test in SPSS22 software.
Results: The physicochemical characterization results demonstrated that all synthesized nanoparticles and nanocapsules possessed a predominantly amorphous structure. The XRD patterns exhibited broad diffraction peaks within the 15–30° range, while the absence of sharp crystalline peaks confirmed the successful incorporation of cellulose nanocrystal–cisplatin complexes into the BSA-PVA matrix and the formation of a homogeneous noncrystalline system. TGA analysis further revealed that increasing the concentration of cellulose nanocrystals from 50 to 200 mg significantly enhanced the thermal stability of CNC-CDP nanoparticles, as higher concentrations remained thermally stable up to nearly 300°C. Moreover, the BPC(100 mg)CP-HA nanocapsules showed lower thermal degradation and greater structural stability compared with drug-free nanocapsules, indicating the reinforcing effect of CNC-CDP within the nanocapsule network. DLS analysis demonstrated that increasing the cellulose nanocrystal concentration increased particle size from 322 to 363 nm, while the zeta potential decreased from +13.05 to +2.14 mV. Surface coating with BSA, PVA, PEG, and hyaluronic acid further increased the particle size to 476 nm and elevated the PDI value, confirming the successful formation of multilayered nanocapsules. Drug release studies indicated that cisplatin release was significantly higher under acidic conditions (pH=5.8) than under physiological conditions (pH=7.4), and the release rate increased over time. In contrast, increasing the cellulose nanocrystal concentration reduced the drug release rate, suggesting a more compact and stable nanostructure. MTT assay results showed that drug-free nanocapsules exhibited negligible cytotoxicity against both AGS and GES-1 cells, whereas cisplatin-loaded nanocapsules significantly reduced the viability of cancer cells. Among all formulations, BPC(50 mg)CP-HA exhibited the strongest anticancer activity, with an IC50 value of 224.75 µg.mL-1 against AGS cells and the highest selectivity index (SI=1.75), indicating superior selective toxicity toward cancer cells. Furthermore, flow cytometry analysis demonstrated that this formulation induced the highest percentages of early and late apoptotic cells, while free cisplatin caused the greatest level of necrotic cell death.
Discussion: In recent years, smart nanocarrier systems have emerged as promising strategies for targeted cancer therapy due to their ability to improve drug stability, provide controlled release, and reduce systemic side effects. In the present study, multifunctional nanocapsules composed of cellulose nanocrystals, BSA, PVA, PEG, and hyaluronic acid were designed for the targeted delivery of cisplatin to AGS gastric cancer cells. The obtained results demonstrated that drug-free nanocapsules exhibited negligible cytotoxicity against both AGS and GES-1 cells, indicating the favorable biocompatibility of the synthesized nanocarrier system. This biocompatibility may be attributed to the intrinsic properties of the nanocarrier components, which are unlikely to induce oxidative stress, membrane damage, or mitochondrial dysfunction in healthy cells. Furthermore, PEGylation and hyaluronic acid-mediated targeting reduced nonspecific nanoparticle accumulation in normal cells while improving selective uptake by cancer cells through CD44 receptor interactions. Physicochemical characterization revealed that increasing the concentration of cellulose nanocrystals resulted in larger particle sizes and lower zeta potential values, likely due to the formation of denser polymeric networks and stronger hydrogen-bonding interactions among the nanocarrier components. Nevertheless, the BPC(100 mg)CP-HA formulation exhibited an appropriate particle size distribution and acceptable uniformity for drug delivery applications. Drug release studies further demonstrated that cisplatin release was significantly higher under acidic conditions than at physiological pH, while increasing cellulose nanocrystal concentration reduced the release rate. This behavior was associated with the formation of a more compact polymeric network that restricted drug diffusion and enabled sustained and controlled release. In addition, flow cytometry analysis revealed that the BPC(50 mg)CP-HA nanocapsules induced the highest levels of apoptosis in AGS cells, whereas free cisplatin predominantly caused necrotic cell death. These findings suggest that encapsulation of cisplatin within the designed nanocarrier system not only enhances anticancer selectivity but also promotes apoptosis-mediated cell death, thereby potentially improving the therapeutic efficacy of cisplatin in gastric cancer treatment.
Conclusion: This study demonstrates that smart nanocapsules BPCCP-HA based on cellulose nanocrystals and a BSA-PVA hydrogel provide an effective strategy to overcome the therapeutic limitations of cisplatin. This system enhances physicochemical properties, structural stability, and pH-responsive drug release, thereby improving targeted delivery of the drug to AGS cancer cells. The designed formulation shows good biocompatibility and low toxicity toward healthy cells.